AtriCure Gains 10%+ After Hours on Q3 Sales Beat and Narrower-Than-Expected Loss
AtriCure Gains 10%+ After Hours on Q3 Sales Beat and Narrower-Than-Expected Loss
AtriCure在第三季銷售超預期並實現虧損幅度較小後盤後上漲10%以上
$AtriCure (ATRC.US)$ rose more than 10% after hours Tuesday after the biotech reported a narrower Q3 loss than expected and beat analyst expectations for revenues.
$AtriCure (ATRC.US)$ 在週二盤後，該生物科技公司公佈的第三季度虧損比預期的較小，並且超出分析師對收入的預期後，其股價上漲超過10%。
ATRC gained 13.8% to $33.50 shortly after 5 p.m. ET after reporting a $0.17 loss per share, which beat the $0.19 that analysts' consensus had called for.
在下午5點過後不久，atricle的股價上漲了13.8%，達到33.50美元，此時該公司每股虧損0.17美元，超過了分析師預期的0.19美元。
The company also said quarterly sales came in at $115.9 million, exceeding analysts' consensus forecast of $112.3 million. Sales also rose 17.9% year over year.
該公司還表示季度銷售額達到11590萬美元，超出分析師11230萬美元的共識預測。銷售額同比增長了17.9%。
資訊熱榜
更新時間